The metabolism of vitamin E involves oxidation of the phytyl chain to generate the terminal metabolite 7,8-dimethyl-2-(b-carboxyethyl)-6-hydroxychroman (CEHC) via intermediate formation of 13 ¶-hydroxychromanol and longchain carboxychromanols. Conjugated (including sulfated) metabolites were reported previously but were limited to CEHCs. Here, using electrospray and inductively coupled plasma mass spectrometry, we discovered that g-tocopherol (g-T) and d-T were metabolized to sulfated 9 ¶-, 11 ¶-, and 13 ¶-carboxychromanol (9 ¶S, 11 ¶S, and 13 ¶S) in human A549 cells. To further study the metabolites, we developed a HPLC assay with fluorescence detection that simultaneously analyzes sulfated and nonconjugated intermediate metabolites.Using this assay, we found that sulfated metabolites were converted to nonconjugated carboxychromanols by sulfatase digestion. In cultured cells, ?45% long-chain carboxychromanols from g-T but only 10% from d-T were sulfated. Upon supplementation with g-T, rats had increased tissue levels of 9 ¶S, 11 ¶S, and 13 ¶S, 13 ¶-hydroxychromanol, 13 ¶-carboxychromanol, and g-CEHC. The plasma concentrations of combined sulfated long-chain metabolites were comparable to or exceeded those of CEHCs and increased proportionally with the supplement dosages of g-T. Our study identifies sulfated long-chain carboxychromanols as novel vitamin E metabolites and provides evidence that sulfation may occur parallel with b-oxidation. In addition, the HPLC fluorescence assay is a useful tool for the investigation of vitamin E metabolism.-Jiang, Q., H. Freiser, K. V. Wood, and X. Yin. Identification and quantitation of novel vitamin E metabolites, sulfated long-chain carboxychromanols, in human A549 cells and in rats. J. Lipid Res. or y-T) and four corresponding tocotrienols] (Scheme 1). All of these molecules have a chromanol ring and a 16 carbon phytyl chain, which are responsible for the potent antioxidant activity and lipophilic property, respectively. Despite structural similarity, different vitamin E forms appear to have distinct bioactivity and to be distinctively metabolized (1, 2). a-T is the predominant vitamin E form in tissues and is the least catabolized. On the other hand, some portions of non-a forms are likely to be readily metabolized and/or excreted directly via the bile (3), because they do not appear to be accumulated to the same extent as a-T in most tissues. To elucidate the potential biological functions of each vitamin E form, it is important to understand their metabolism and to identify the major metabolites in the body.The understanding of how vitamin E is metabolized was initiated by the identification of their urine-excreted metabolites. The water-soluble metabolite of y-T, y-7,8-dimethyl-2-(b-carboxyethyl)-6-hydroxychroman (CEHC), was first found in rat urine (4) (Scheme 1). Subsequently, g-CEHC and a-CEHC were identified to be the major urine-excreted metabolites of g-T and a-T, respectively (5-9). g-CEHC has been shown to have natriuretic activity (9) and to inhibit t...